Skip Navigation LinksHome > October 2012 - Volume 34 - Issue 7 > Cutaneous Reactions to Novel Therapeutics
Text sizing:
American Journal of Dermatopathology:
doi: 10.1097/DAD.0b013e31822e67eb
CME Article

Cutaneous Reactions to Novel Therapeutics

Hoang, Mai P. MD*; Kroshinsky, Daniela MD

Continued Medical Education
Collapse Box


Abstract: In the last 2 decades the introduction new biologic agents such as tumor necrosis factor alpha inhibitors has resulted in potent disease modifying effects in a variety of immune-mediated diseases. In addition, there were major advancements in cancer treatment due to chemotherapeutic agents including granulocyte macrophage-colony-stimulating factor, interferon, epidermal growth factor receptor inhibitors, and kinase inhibitors for the treatment of hematologic malignancies as well as solid tumors. However, a variety of toxicities including cutaneous reactions is seen in association with these agents. Awareness of commonly associated skin toxicities and recognition of corresponding histologic features is of importance.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.